Clinical Trial: Risk Stratification and Prediction of Post-Renal Transplant Pneumocystis Pneumonia Using Integrated Immune, Molecular and Microbiomic Profiles (China)

China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk Stratification and Prediction of Post-Renal Transplant Pneumocystis Pneumonia Using Integrated Immune, Molecular and Microbiomic Profiles'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130150

Registration Time: 2026/08/16

Type: Observational study

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337870

Published by HT Digital Content Services with permission from Health Daily Digest....